GLPwatch
Trials (2081)
Page 12 of 35.
- Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
- Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures
- Comparison of Body Composition Changes With Weight Loss Interventions
- BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantation
- Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes
- Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
- A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)
- A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function
- Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents
- Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity
- Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment
- Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss
- Effect of Liraglutide on Clock Genes
- Efficacy of Semaglutide in Glycemic Control, Weight Loss, and Improving Lipidogram- Role of Baseline Vitamin D Levels
- Randomized Control Trial of Sleeve Gastrectomy With Tirzepatide in Maximizing Weight Loss
- Tirzepatide (Spartina) in Obese Kidney Transplant Recipients
- Exenatide for Myocardial Protection During Reperfusion Study
- Semaglutide Therapy for Alcohol Reduction (STAR)
- Liraglutide Hospital Discharge Trial
- Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes
- A Study of Two Different Formulations of LY3502970 in Healthy Participants
- A Phase I Study of 8-week Continuous Treatment With Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
- STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
- Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With Type 2 Diabetes
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
- Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers
- Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI
- A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
- A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) Dose
- Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie Diet
- A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight
- Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19
- Effect of Semaglutide and Tirzepatide Combined With Exercise in Obesity
- Changes in Taste and Eating Habits Associated With GLP-1 Agonists in Weight Loss Patients
- Gastric Ultrasound To Assess Gastric Contents In Patients On Semaglutide Therapy
- GLP-1 REceptor Agonists and Real World EvIdeNce
- A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)
- A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese Participants
- A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India
- The Effect and the Pharmacogenomics Study of Liraglutide in Obese Patients
- Real World Effectiveness of Oral Semaglutide in Thailand Participants With Type 2 Diabetes
- A Research Study Looking at the Comparability (Bioequivalence) of Two Versions of Semaglutide
- A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight
- Liraglutide and a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and CVD.
- Incretin-based Drugs and the Risk of Heart Failure
- A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 Diabetes
- The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients
- Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)
- Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin
- Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
- Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
- Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health
- PREDnisolone-induced Beta-cell Dysfunction Prevented by EXenatide
- Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DM
- A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use
- Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
- A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years
- Evaluation of Gastric Content of Volunteers Fasting and Using Semaglutide: an Observational and Cross-sectional Study